Hyperliquid Strategies (NASDAQ:PURR) Stock Price Up 10.2% – Still a Buy?

Hyperliquid Strategies Inc (NASDAQ:PURR)’s share price was up 10.2% on Monday . The company traded as high as $8.75 and last traded at $8.8740. Approximately 3,537,570 shares traded hands during trading, a decline of 58% from the average daily volume of 8,516,069 shares. The stock had previously closed at $8.05.

Analyst Upgrades and Downgrades

Several research analysts have commented on PURR shares. Maxim Group initiated coverage on shares of Hyperliquid Strategies in a report on Friday, April 24th. They issued a “buy” rating and a $10.00 price target for the company. Chardan Capital reiterated a “buy” rating and issued a $9.75 price objective on shares of Hyperliquid Strategies in a research report on Friday, June 12th. Weiss Ratings raised Hyperliquid Strategies from a “sell (d)” rating to a “sell (d+)” rating in a research note on Wednesday, June 3rd. Finally, Cantor Fitzgerald boosted their target price on Hyperliquid Strategies from $8.00 to $18.40 and gave the stock an “overweight” rating in a research report on Wednesday, July 1st. Three equities research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $12.72.

Hyperliquid Strategies Price Performance

The company has a market capitalization of $1.28 billion, a price-to-earnings ratio of -1.21 and a beta of 1.66. The stock’s 50 day moving average is $8.01.

Hyperliquid Strategies (NASDAQ:PURR) last released its quarterly earnings results on Thursday, May 7th. The company reported $1.01 EPS for the quarter. The company had revenue of $2.63 million during the quarter. On average, equities research analysts anticipate that Hyperliquid Strategies Inc will post 2.1 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the company. Boothbay Fund Management LLC purchased a new stake in Hyperliquid Strategies during the fourth quarter valued at about $40,000. XTX Topco Ltd bought a new position in shares of Hyperliquid Strategies during the 4th quarter valued at about $48,000. Squarepoint Ops LLC bought a new position in shares of Hyperliquid Strategies during the 4th quarter valued at about $73,000. Private Advisor Group LLC purchased a new position in shares of Hyperliquid Strategies during the 1st quarter valued at about $83,000. Finally, Millennium Management LLC purchased a new position in shares of Hyperliquid Strategies during the 4th quarter valued at about $87,000. Institutional investors own 9.45% of the company’s stock.

Hyperliquid Strategies Company Profile

Hyperliquid Strategies Inc is a digital asset treasury company whose primary focus is to maximize shareholder value through accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. Hyperliquid Strategies Inc, formerly known as Sonnet BioTherapeutics Holdings Inc, is based in NEW YORK.